Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.

[1]  S. Steffens,et al.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly , 2018, Nature Reviews Cardiology.

[2]  M. Pomper,et al.  Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.

[3]  Sean R. Donohue,et al.  In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors , 2014, NeuroImage.

[4]  O. Ratib,et al.  Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines. , 2013, European heart journal.

[5]  V. Dilsizian,et al.  Clinical ResearchCardiac Imaging: Editorial CommentCardiac Positron Emission Tomography/Computed Tomography Imaging of the Renin-Angiotensin System in Humans Holds Promise for Image-Guided Approach to Heart Failure Therapy⁎ , 2012 .

[6]  Z. Szabo,et al.  Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors. , 2012, Journal of the American College of Cardiology.

[7]  O. Ratib,et al.  Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. , 2012, JACC. Cardiovascular imaging.

[8]  V. Dilsizian,et al.  Molecular imaging of human ACE-1 expression in transgenic rats. , 2012, JACC. Cardiovascular imaging.

[9]  K. Mackie,et al.  Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy , 2012, Diabetes.

[10]  K. Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[11]  Dean F. Wong,et al.  Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR , 2010, NeuroImage.

[12]  Jeih-San Liow,et al.  Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand , 2009, NeuroImage.

[13]  L. Liaudet,et al.  Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. , 2007, Journal of the American College of Cardiology.

[14]  Valerie Treyer,et al.  Evaluation of the Metabotropic Glutamate Receptor Subtype 5 Using PET and 11C-ABP688: Assessment of Methods , 2007, Journal of Nuclear Medicine.

[15]  Arman Rahmim,et al.  11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.